{"url_path":"/sec/pbsv/10-q/2026/item-2","section_key":"item-2","section_title":"Item 2 ****UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.**","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-06-15","source_url":"https://www.sec.gov/Archives/edgar/data/1304161/0001654954-26-005986-index.html","accession_number":"0001654954-26-005986","cik":"0001304161","ticker":"PBSV","issuer_name":"Pharma-Bio Serv, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1304161/0001654954-26-005986-index.html","primary_entity_key":"0001304161","primary_entity_name":"Pharma-Bio Serv, Inc."},"word_count":232,"has_tables":true,"body_markdown":"**ITEM 2.****UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.**\n\n \n\n(c) The following table provides information about purchases by the Company of its shares of common stock during the three-month period ended April 30, 2026:\n\n \n\n**Period**\n\n \n\n**Total Number**\n\n**of Shares**\n\n**Purchased**\n\n \n\n \n\n**Average**\n\n**Price Paid**\n\n**per Share**\n\n \n\n \n\n**Total**\n\n**Number of Shares**\n\n**Purchased as**\n\n**Part of Publicly**\n\n**Announced Plans or Programs (1)**\n\n \n\n \n\n**Maximum**\n\n**Number** **of Shares**\n\n**that May** **Yet Be**\n\n**Purchased Under the Plans or**\n\n**Programs** **(1)**\n\n \n\nFebruary 1, 2026 through February 28, 2026\n\n \n\n \n1,200\n \n\n \n$0.59\n \n\n \n\n \n1,200\n \n\n \n\n \n1,444,992\n \n\nMarch 1, 2026 through March 31, 2026\n\n \n\n \n-\n \n\n \n$-\n \n\n \n\n \n-\n \n\n \n\n \n1,444,992\n \n\nApril 1, 2026 through April 30, 2026\n\n \n\n \n-\n \n\n \n$-\n \n\n \n\n \n-\n \n\n \n\n \n1,444,992\n \n\nTotal\n\n \n\n \n1,200\n \n\n \n$0.59\n \n\n \n\n \n1,200\n \n\n \n\n \n\n \n\n \n\n \n\n(1)\n\nOn June 16, 2014, the Company announced that the Board of Directors of the Company approved the Repurchase Program authorizing the Company to repurchase up to two million shares of its outstanding common stock. The timing, manner, price and amount of any repurchases under the Repurchase Program will be at the discretion of the Company, subject to the requirements of the Exchange Act Rules. The Repurchase Program does not oblige the Company to repurchase any shares and it may be modified, suspended or terminated at any time and for any reason. The Repurchase Program has no expiration date. No shares will be repurchased under the Repurchase Program directly from directors or officers of the Company.\n\n \n\n \n\n20\n\n*Table of Contents*"}